UnannouncedVCInvestor

Valence Advantage Life Sciences

Startup rounds since 2017 with a Valence Advantage Life Sciences investor on the board, and the firm's own fund filings.

Raises
16
since 2017
Unannounced
0
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name

Rounds

  1. Palvella Therapeutics, Inc.$9.7MFiled before 202530 Dec 2022 · Wayne, PA
  2. Antios Therapeutics Inc.$75MFiled before 202516 Nov 2021 · Mendham, NJ
  3. Antios Therapeutics Inc.$32MFiled before 202519 Apr 2021 · Mendham, NJ
  4. Primmune Therapeutics, Inc.$13MFiled before 20256 Nov 2020 · San Diego, CA
  5. Antios Therapeutics Inc.$4.4MFiled before 202517 Aug 2020 · Atlanta, GA
  6. Palvella Therapeutics, Inc.$45MFiled before 20253 Jun 2020 · Wayne, PA
  7. Primmune Therapeutics, Inc.$2.5MFiled before 202517 Mar 2020 · San Diego, CA
  8. Primmune Therapeutics, Inc.$2MFiled before 202517 Mar 2020 · San Diego, CA
  9. Primmune Therapeutics, Inc.$1.1MFiled before 202517 Mar 2020 · San Diego, CA
  10. Molecular Templates, Inc.$15MFiled before 20253 Dec 2019 · Austin, TX
  11. Velicept Therapeutics, Inc.$6MFiled before 202519 Nov 2019 · Wayne, PA
  12. Antios Therapeutics Inc.$15MFiled before 20255 Dec 2018 · Atlanta, GA
  13. Velicept Therapeutics, Inc.$15.5MFiled before 202518 Jul 2018 · Wayne, PA
  14. Molecular Templates, Inc.$20MFiled before 202515 Aug 2017 · Austin, TX
  15. Molecular Templates, Inc.$40MFiled before 202515 Aug 2017 · Austin, TX
  16. Velicept Therapeutics, Inc.$18.4MFiled before 202520 Apr 2017 · Malvern, PA

By year

YearRaisesUnannounced
20221—
20212—
20206—
20192—
20182—
20173—

Raises are checked for an announcement from 2025 on.

Funds

The firm's own fund filings, each at its latest filing.

FundFiledSizeRaised
Valence Advantage Life Sciences Fund II, L.P.14 Mar 2012$175M—

Listed because a Valence Advantage Life Sciences fund's filing names a director of each company. A name match is not a verified identity.